Assessment of Lipocalin 2, Clusterin, Soluble Tumor Necrosis Factor Receptor-1, Interleukin-6, Homocysteine, and Uric Acid Levels in Patients with Psoriasis

Table 1

Demographic and laboratory findings of psoriasis and healthy control groups.

	Psoriasis	Control
𝑛	56	33
Age	39.75 ± 18.29	36.18 ± 14.19
Male/female	21/35	11/22
PASI	8.3 ± 6.5
BMI (kg/m^2)	26.7 ± 5.8	25.7 ± 5.1
Lipocalin 2 (ng/mL)	2.54 ± 0.46 **	2.07 ± 0.39
Clusterin (ng/mL)	2.55 ± 0.26	2.52 ± 0.18
sTNFR-1 (ng/mL)	0.33 ± 0.15 *	0.26 ± 0.06
IL-6 (pg/mL)	0.14 ± 0.3	0.13 ± 0.02
Homocysteine (𝜇mol/L)	13.55 ± 8.3	16.04 ± 9.3
Uric acid (mg/dL)	4.48 ± 1.2	4.20 ± 0.9

PASI: psoriasis area severity index; BMI: body mass index.
^∗𝑃<0.05;  ^∗∗𝑃<0.001.